That said I think the academic and pharma communities had engineered themselves into a corner and weren't going to see huge gains (even thogh they are exploring similar ideas) for a number of banal reasons.
What I meant to focus on was that I think DeepMind has less of a pure money/scale advantage in this area than in some others. In something like Go or Atari game-playing, there are many academic groups researching similar things, but their resources are laughably small compared to what DeepMind threw at it. So you might argue that they got good results there in part because they directed 1000x the personnel and compute at the problem compared to what any academic group could afford. In biomed though, their peers in academia and industry are also pretty well-funded.
Here's an exemplar of how I think it evolved well in a cloud world: https://gnomad.broadinstitute.org/
that project adopts many concepts from google and others and greatly improved our analytic capabilities for large-scale genomics.
The research is the giant shoulders you stand on, the compute cost is the price of the tool you need to do the present-day work.
Both are relevant but the shoulder’s of giants are generally more accessible, particularly if we’re talking about published research and not proprietary tech.
A competing team is not starting from the same place the DeepMind team started at 5 or 10 years ago.
> I don’t think we would do ourselves a service by not recognizing that what just happened presents a serious indictment of academic science. There are dozens of academic groups, with researchers likely numbering in the (low) hundreds, working on protein structure prediction. We have been working on this problem for decades, with vast expertise built up on both sides of the Atlantic and Pacific, and not insignificant computational resources when measured collectively. For DeepMind’s group of ~10 researchers, with primarily (but certainly not exclusively) ML expertise, to so thoroughly route everyone surely demonstrates the structural inefficiency of academic science. This is not Go, which had a handful of researchers working on the problem, and which had no direct applications beyond the core problem itself. Protein folding is a central problem of biochemistry, with profound implications for the biological and chemical sciences. How can a problem of such vital importance be so badly neglected?
In short, academia got utterly schooled by a small group at Google spending a relatively small dollar amount on compute, using techniques that in hindsight are fairly described as "simplistic". There's no way around it.
If you were trying to get across the Atlantic, this would be like getting upset at a group of bridgebuilders for trying to solve the problem by building a bridge across instead of by inventing the airplane. The approaches are that different.
>The approaches are that different.
I'm not sure if that analogy applies here. DeepMind wasn't the first group tackling structure prediction with machine learning. Their success lies in the innovations that they implemented (predicting interresidue distances as opposed to contacts, for example).
Meaningless in historical terms, but meaningful in future terms. It's meaningless how long the training took because there were countless resources spent to get to that point. It's meaningful in the future, because we know that training times are fairly short, and iteration can be done fairly quickly.
These years of research involved trying many different architectures, many of which received as much or more compute time than the final system.
The price of training the final architecture is meaningless. Researching and training AlphaGo was expensive but it enabled the ideas and development of AlphaZero which is more computationally tractable.
To have any chance, an academic team would need the same compute resources as what the DeepMind protein folding team used during the whole development of the architecture during the last few years, not only the resources used to train the final system. And I bet this funding is not available to most if not all academic teams.